Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-22 Sale | 2022-08-23 9:00 pm | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 4,615 | $3.8507 | $17,771 | 777,075 (Direct) | View |
| 2022-07-31 Purchase | 2022-08-01 06:00 am | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 5,000 | $2.93 | $14,650 | 781,690 (Direct) | View |
| 2022-02-28 Purchase | 2022-03-01 5:01 pm | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 36,900 | $2.71 | $99,999 | 576,690 (Direct) | View |
| 2022-01-31 Purchase(A) | 2022-02-09 9:00 pm | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 1,804 | $3.17 | $5,719 | 539,790 (Direct) | View |
| 2022-01-31 Purchase | 2022-02-02 5:00 pm | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 2,334 | $3.17 | $7,399 | 540,320 (Direct) | View |
| 2021-07-30 Purchase | 2021-08-02 8:00 pm | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 5,000 | $2.99 | $14,950 | 547,602 (Direct) | View |
| 2020-12-08 Purchase(A) | 2020-12-10 6:57 pm | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 34,602 | $2.89 | $100,000 | 398,602 (Direct) | View |
| 2018-11-14 Purchase | 2020-12-10 5:07 pm | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 34,602 | $2.89 | $100,000 | 398,602 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-02-28 Option Award(A) | 2022-08-24 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 36,900 | $2.71 | 576,690 (Direct) | View |
| 2022-07-31 Option Award(A) | 2022-08-24 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 5,000 | $2.93 | 781,690 (Direct) | View |
| 2022-01-31 Option Award(A) | 2022-08-24 9:00 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 1,804 | $3.17 | 539,790 (Direct) | View |
| 2022-05-18 I(A) | 2022-05-25 8:00 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 4,789 | $3.19 | 776,690 (Direct) | View |
| 2022-05-18 Tax Withholding | 2022-05-20 8:00 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 4,789 | $3.19 | 771,901 (Direct) | View |
| 2022-05-10 Option Award | 2022-05-12 8:01 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro EVP Endocrine Business Unit | 200,000 | $0 | 776,690 (Direct) | View |
| 2021-08-27 Tax Withholding | 2021-08-27 9:01 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 9,616 | $4.91 | 537,986 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-20 5:00 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 144,000 | $0 | 542,602 (Direct) | View |
| 2020-08-27 Option Award | 2020-08-31 7:07 pm | N/A N/A | MANNKIND CORP | MNKD | Galindo Alejandro Chief Commercial Officer | 364,000 | $0 | 364,000 (Direct) | View |